n boys in the neonatal care setting. ML390 EAP in neonates might potentially be used for diagnosis and therapeutic opinions in neonates in the future.X-linked inhibitor of apoptosis (XIAP) deficiency is a rare inborn error of immunity first described in 2006. XIAP deficiency is characterised by immune dysregulation and a broad spectrum of clinical…[Read more]